Dolores Isla, MD
Hospital Lozano Blesa · Medical Oncology Service. Hospital Clinico Lozano Blesa. Zaragoza. Spain · Hospital Clínico Lozano Blesa (Zaragoza)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dolores Isla, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:16 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02709720 · Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLCSpanish Lung Cancer Group · completed · Lung Cancer · principal investigator
- Ph1/Ph2NCT00503971 · Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.Spanish Lung Cancer Group · terminated · Non-small Cell Lung Cancer · study chair
- Ph2NCT00324558 · Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)Clinica Universidad de Navarra, Universidad de Navarra · terminated · Carcinoma, Small Cell · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.